Introducing Dante Labs Business: A B2B Portal for Advanced Genetics Dedicated to Healthcare Professionals and Researchers

LONDON, May 28, 2019 /PRNewswire/ — Dante Labs today announced the launch of Dante Labs Business for Healthcare Professionals and Researchers (http://b2b.dantelabs.com), a new portal that combines advanced analytics, access to newest technologies and genetics expertise that thousands of individuals have come to know and love from Dante Labs, with new features and exclusive services tailored for healthcare professionals and researchers.

Dante Labs B2B customers will find tests and reports for their needs, special business-only pricing and billing. New services will be launched in the coming months, which leverage the power of sequencing in the research and healthcare space.

Some of the tests available to healthcare professionals and researchers include:

  • Pharmacogenomic Tests
  • ACMG Panels
  • Immunology Panels
  • Long Read Whole Genome Sequencing

Customers have access to volume discounts, with different tiers.

“Private clinics and researchers have come to value the services and technical support of Dante Labs,” said Andrea Riposati, CEO of Dante Labs. “We have heard their requests for a more tailored online buying experience and for additional services that cannot be offered to individuals. We aim at bringing advanced genetics to all the researches and healthcare professionals that can’t afford to purchase and run their own sequencing equipment and create their own reporting pipelines.”

New customers must request access to the Dante Labs B2B Portal by registering on the website (http://b2b.dantelabs.com). Only accredited clinics, doctors, healthcare professionals and researchers will be granted access.

To apply for a free Dante Labs B2B account, please visit b2b.dantelabs.com.

Media Contact: 
Francesco Pennelli
Phone: +39-3206-030072
Email: francesco@dantelabs.com

Related Files

Dante Labs – Sample_Pharmacogenetics_Report.pdf

Dante Labs – Sample_Comprehensive_Epilepsy_Panel_Positive.pdf

Related Images

image1.png
image2.jpg

dante-labs-ceo-andrea-riposati.jpg
Dante Labs CEO Andrea Riposati

Related Links

Dante Labs Business

Dante Labs

View original content to download multimedia:http://www.prnewswire.com/news-releases/introducing-dante-labs-business-a-b2b-portal-for-advanced-genetics-dedicated-to-healthcare-professionals-and-researchers-300857542.html

SOURCE Dante Labs

Staff

Recent Posts

Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring

PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…

9 hours ago

Defence Announces Closing of Securities for Debenture Financing

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…

14 hours ago

NuGen Announces Canada-Wide Launch of InsuJet

3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…

15 hours ago

purelyIV Launches Mobile App for Seamless Wellness Management

The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…

15 hours ago

Independence Blue Cross launches Epic Payer Platform to transform care coordination and boost member health outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform…

15 hours ago